FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT FOR SELECTED APPLICATIONS OF COATED NANOCRYSTALLINE PARTICLES BETWEENExclusive License Agreement • March 24th, 2000 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 24th, 2000 Company Industry